Speakers

meet the panelists

See how our panelists are defining innovation

Panelists include scientists who turned patents into industry-defining platforms, investors backing the frontier tech of tomorrow, and founders transforming R&D into global ventures.

From the co-founder of Cadence and Synopsys; two companies worth over $160B, to the VC behind over 20 unicorns including Alibaba and Grab, and the Stanford professor redefining human-robot interaction, our panelists shape the course of our modern world.

KEYNOTE & OPENING
Prof. Alberto Sangiovanni-Vincentelli
UC Berkeley
Track 0
1
/
Future 
Logic
 Speakers
Dr. Tan Sian Wee
Moderator / NUS
Dr. Guido Appenzeller
Andreessen Horowitz
Ms. Jenny Lee
Granite Asia
Dr. Krishna Palem
Accelequant
Mr. Sidu Ponnappa
Realfast
Dr. Thuc Vu
OhmniLabs
Track 0
2
/
Future 
Pulse
 Speakers
Ms. Donna See
Moderator / NUS
Prof. Oussama Khatib
Stanford University
Dr. Dima Kuzmin
4BIO Capital
Mr. Paul Sciabetta
22Health Ventures
Dr. Christopher Shen
Novo
Track 0
3
/
Future 
Matter
 Speakers
Dr. Patrick Ennis
Moderator / Madrona
Mr. Jay Eum
GFT Ventures 
Mr. Fred Farina
Caltech
Dr. Wen Hsieh
Matter Venture Partners
Mr. Aditya Mathur
elev8 
Prof. Alberto Sangiovanni-Vincentelli
UC Berkeley
Panel – Innovation Unplugged: Founders & Frontiers
Assoc. Prof. Benjamin Tee
Moderator / NUS Enterprise
Prof. Dario Campana
NUS
Prof. Abhik Roychoudhury
NUS
Assoc. Prof. Shao Huilin
NUS
Assoc. Prof. Too Heng Phon
NUS
Keynote & Exclusive Networking Dinner (by invitation only)
Dr. Edward Jung
Intellectual Ventures
Remarkable Achievements:
Mr. Jay Eum
Managing Partner, GFT Ventures 
Jay, with 25 years of venture capital experience, is a seasoned investor across institutional and corporate firms specialising in frontier technology sectors like AI, robotics, cybersecurity, fintech, digital healthcare, and mobility. As founder of GFT Ventures and co-founder of TransLink Capital, Jay has led investments in transformative start-ups such as Carbonite, Chartboost, SoundHound AI, and many others. He serves as Chairman and Board Director of the Asia America MultiTechnology Association.
Remarkable Achievements:
  • Founding Managing Partner of GFT Ventures, investing early in cutting-edge tech start-ups shaping the future
  • Co-founder of TransLink Capital, fostering Asian market connections for innovation-driven entrepreneurs
  • Former Managing Director of Samsung Ventures, leading US venture capital operations and key investments in NASDAQ listed and acquired companies
  • Early investor and advisor to influential start-ups including Coupang, SoFi, KiwiCo, and Korbit
  • Board Chairman of AAMA, advancing cross-border technology entrepreneurship and partnerships
Why listen to him
Jay’s over two decades of hands-on VC leadership and deep cross-border tech expertise provide unparalleled insights into scaling start-ups, building global partnerships, and driving innovation across Asia and Silicon Valley.
Prof. Dario Campana
Professor, Department of Paediatrics; Senior Principal Investigator, Cancer Science Institute, Yong Loo Lin School of Medicine, NUS
Dario is a world-leading innovator in cancer immunotherapy whose breakthroughs include the first anti-CD19-41BB-CD3 zeta chimeric antigen receptor and effective treatments for T-cell leukemia and lymphoma. Formerly Vice Chair for Laboratory Research at St. Jude Children’s Research Hospital and Professor at the University of Tennessee, he is an inventor on over 30 granted or licensed patents and founder of three biotechnology companies, two of which became publicly traded in the US. His technologies to activate and genetically modify immune cells are advancing through multiple clinical trials worldwide.
Remarkable Achievements:
  • Recipient of the 2023 Premio Farnesina – Italian Bilateral Scientific Award for international scientific collaboration
  • Honoured with the 2021 Singapore STaR Investigator Award by the Ministry of Health, one of Singapore’s most prestigious honors for clinician scientists that recognises their achievements and enabling long-term impactful research in healthcare
  • Winner of the 2020 Republic of Singapore President’s Technology Award, the nation’s highest honor in applied research
  • Received the 2019 Jacob and Louise Gabbay Award in Biotechnology and Medicine for pioneering advances in the field
  • Conferred the 2009 American Association for Cancer Research Team Science Award for groundbreaking collaborative work
Why listen to him
Dario offers rare, first-hand expertise in transforming cutting-edge biomedical discoveries into successful start-ups and life-changing therapies. As an NUS professor and biotech founder with a proven record of turning laboratory breakthroughs into publicly traded companies and approved treatments, he offers practical, actionable strategies for researchers aiming to commercialise their work. His unique blend of academic excellence and entrepreneurial success delivers powerful lessons on bridging science, business, and patient impact.
Dr. Edward Jung
Co-Founder and Chief Technology Officer, Intellectual Ventures
Edward is the Co-Founder and CTO of Intellectual Ventures (IV), where he leads one of the world’s largest invention investment firms. With a background as Chief Architect at Microsoft, he holds more than 1,200 patents and co-founded IV to pioneer new models for global invention, technology transfer, and advanced R&D. His influential work spans AI, life sciences, energy, and pandemic preparedness, cementing his role as a transformative force in both academia and industry.
Remarkable Achievements:
  • Ranked among the world’s top inventors, with 1,200+ patents licensed globally across fields like social media, energy, materials, and healthcare
  • Former Chief Architect at Microsoft, shaping the company’s long-term technological vision
  • Helped launch transformational projects in global health, clean energy, and artificial intelligence
  • Member of the National Academy of Engineering and recipient of multiple innovation awards
  • Advisor to governments and Fortune 500 companies on future technologies, IP, and strategic R&D
Why listen to him
Edward bridges visionary invention with practical global impact, showing how deep tech, intellectual property strategy, and cross-disciplinary teams spark breakthrough innovation. He’ll share actionable insights on turning big ideas into world-changing outcomes—across sectors and continents.
Assoc. Prof. Shao Huilin
Associate Professor, Biomedical Engineering & Institute for Health Innovation & Technology, NUS
Huilin is a biomedical engineer and translational innovator from NUS, whose work empowers clinical decisions through precise diagnostics. She’s behind the world’s first real-time blood test to monitor cancer drug effectiveness and has developed rapid molecular tools for Alzheimer’s and Covid detection.
Remarkable Achievements:
  • Created the first blood-based cancer drug‑response test, enabling real-time treatment decisions
  • Invented MATCH and ExoSCOPE platforms, integrating nanosensors and multiplexed analysis for biomarker profiling in clinical samples
  • Honors include President’s Young Scientist Award, NUS Early Career Research Award, and the 2022 Journal of Nanobiotechnology Rising Star Award for molecular sensor innovation
Why listen to her
She’s redefining diagnostics, delivering next-gen tools that transform care decisions through science that’s being applied and impacting the real world.
Assoc. Prof. Too Heng Phon
Associate Professor, Department of Biochemistry & Centre for Cancer Research, NUS
Too is a molecular biologist and biotech founder behind the world’s first blood test for early gastric cancer detection. As a professor at NUS and co-founder of MiRXES, he’s transformed lab discoveries into life-saving diagnostics used across Asia, pioneering the global application of microRNA technology in clinical settings.
Remarkable Achievements:
  • Invented and commercialised a patented microRNA assay used in early cancer detection
  • Co-founded MiRXES, now a global leader in microRNA diagnostics and research tools
  • Enabled the first CE-marked blood test for early gastric cancer detection
  • Winner of the President’s Technology Award (2021) for diagnostic innovation
  • Filed 18+ inventions, published over 100 papers, spanning cancer biology, molecular engineering, and translational research
Why listen to him
Too bridges world-class academic science with real-world medical impact—bringing life-saving diagnostics from bench to bedside at global scale.
Prof. Abhik Roychoudhury
Provost's Chair Professor of Computer Science, NUS 
Abhik leads NUS flagship research in trustworthy software and automated program repair. His lab spun out AutoCodeRover—acquired by SonarSource—and is a global thought leader in automatic programming and AI for software engineering.
Remarkable Achievements:
  • AutoCodeRover: NUS spinoff acquired by SonarSource, advancing AI-powered code repair.
  • 2023 ICSE Most Influential Paper (10-year Test of Time Award): pioneering semantic automatic program repair
  • 2024 ACM Fellow: recognized for major contributions to software testing, symbolic execution, and program repair
  • Academic leadership: Program Co-Chair ICSE 2024, General Chair FSE 2022, EIC of ACM TOSEM, and Chair of FSE steering committee
Why listen to him
He’s building the future of software: repairing systems with AI, leading global conference agendas, and translating academic research into commercial impact.
Assoc. Prof. Benjamin Tee
Vice President, Innovation and Enterprise, NUS Enterprise
Benjamin is a Stanford trained materials scientist,Y Combinator alum, and inventor of electronic skin technologies. He’s co-founded three deep tech start-ups and now leads ecosystem building at NUS Enterprise.
Remarkable Achievements:
  • Named a MIT TR35 Global Innovator (2015) and the Singapore Young Scientist of the Year (2016)
  • Recognized as a World Economic Forum Young Scientist (2019) and top Clarivate Highly Cited Researcher (2021)
  • Co‑founded Privi Medical, Hannah Life Technologies (YC 20), and Tacniq.AI
Why listen to him
Benjamin blends deep scientific insight with ecosystem leadership. He has a track record of scaling ventures and turning research into real-world impact.
Dr. Krishna Palem
Founding CEO, Accelequant
Krishna is the founder of Accelequant, a quantum computing startup tackling real-world problems with breakthrough speed and scalability. A pioneer of inexact computing, his innovations have been hailed by MIT Technology Review and IEEE as globally transformative.
Remarkable Achievements:
  • Credited as an inventor of inexact computing, recognised as a top technology shaping the future by the MIT Tech Review and IEEE
  • Professor at Rice University, with prior appointments at Caltech, NYU, NTU Singapore, and the Hebrew University of Jerusalem
  • Fellow of AAAS, ACM, IEEE; recipient of the Guggenheim Fellowship and IEEE computer society's highest technical award
  • Former cofounder and CTO of Proceler, a VC-backed embedded systems start-up
Why listen to him
Krishna has spent decades pushing the boundaries of computation, from theory to scalable commercial technologies. He bridges academic insight with venture-backed innovation to bring quantum computing into practical deployment today; not years from now.
Dr. Patrick Ennis
Venture Partner, Madrona
Patrick is a physicist turned venture capitalist with a global track record of turning breakthrough science into real-world ventures. With experience across Bell Labs, ARCH Venture Partners, and Intellectual Ventures, he’s helped launch start-ups, scale innovation platforms, and shape R&D ecosystems from the U.S. to Asia.
Remarkable Achievements:
  • Built early core optical and network systems at Bell Labs, Lucent, and AT&T
  • Helped launch Impinj (IPO) and Innovalight (acquired by DuPont) as Managing Director at ARCH Venture Partners
  • Led start-up incubation at Intellectual Ventures, bridging research + venture creation across Asia
  • Co-founded Xinova, a global innovation network commercialising IP from universities and labs
  • A Yale Physics PhD and Wharton MBA
Why listen to him
Patrick has built companies from deep science and brought lab innovations to market across three continents. He knows how to turn research into reality.
Dr. Tan Sian Wee
Senior Vice President (Innovation and Enterprise), NUS
Sian joined NUS in January 2025 to lead NUS Enterprise, driving the university’s mission to bridge research, education, and commercialisation. With deep roots in Silicon Valley and a track record that spans multiple continents, he brings exceptional global insight into tech-driven entrepreneurship.
Remarkable Achievements:
  • Pioneered modern haptics at Immersion (NASDAQ: IMMR), credited with 10 patents now used in billions of devices worldwide
  • Built Fraunhofer’s spin-out engine and advised Primesense– acquired by Apple and embedded in Face ID
  • Scaled Finaxar as CEO
  • Helped launch Monk’s Hill Ventures by advising their first fund and guided Elev8.vc as a strategic advisor
  • Stanford-trained engineer with a Ph.D. in agent-based distributed manufacturing systems
Why listen to him
Sian brings a rare combination of academic depth and commercial execution. With a global track record in venture creation, technology transfer, and institutional innovation, he offers clear insight into how universities can translate research into scalable impact.
Ms. Donna See
NUS Board of Trustees
Donna’s role at NUS is ensuring the university is globally competitive at commercialising deep tech innovations. She has co-founded, operated, and invested in university spin-offs and held senior leadership roles at the nexus of science, business, and intellectual property, including as Director at Columbia Technology Ventures and founding CEO of Xora Innovation.
Remarkable Achievements:
  • Former CEO of Xora Innovation, leading investments in emerging scientific breakthroughs
  • Former Chief Business Officer at TARA Biosystems, advancing human tissue models for drug discovery
  • Led tech transfer and spinouts at Columbia University, managing over 400 innovation projects
  • Co-founded Vixen Pharmaceuticals, whose work on autoimmune dermatologic therapies led to acquisition by Aclaris Therapeutics (trading as Olumiant®, Eli Lilly)
Why listen to her
Donna brings deep experience bridging science, business, and capital. She has spent decades turning breakthrough technologies into real-world scientific and commercial impact.
Dr. Wen Hsieh
Founding Managing Partner, Matter Venture Partners
Wen Hsieh is a pioneering HardTech investor and Founding Managing Partner at Matter Venture Partners, formerly with Kleiner Perkins. A Caltech-trained engineer and biologist, he’s driven breakthroughs in AI, robotics, semiconductors, and spacetech, with a background in start-ups and McKinsey.
Remarkable Achievements:
  • Led the growth of breakthrough start-ups in semiconductors, AI hardware, energy, space, and robotics at Kleiner Perkins and Matter Venture Partners
  • Helped scale innovators like DJI, Amprius, and Bloom Energy
  • Co-founded Matter Venture Partners to back technical founders solving real-world industrial problems
Why listen to him
Wen Hsieh will delve into how HardTech and AI are converging to transform industries like semiconductors, robotics, and manufacturing. Sharing lessons from partnering with bold founders and building lasting companies at the intersection of atoms and intelligence.
Mr. Fred Farina
Chief Innovation and Corporate Partnerships Officer, Caltech
Fred heads Caltech’s Tech Transfer & Corporate Partnerships, managing innovation, start-ups, and licensing from Caltech and NASA’s JPL. He holds engineering degrees from INSA Lyon and Caltech, and is a registered U.S. patent agent.
Remarkable Achievements:
  • Built Caltech’s tech transfer from the ground up since 1995, evolving from licensing to venture creation
  • Launched translational programs including gap funding, EIRs, incubators, and Caltech’s first internal seed funds
  • Forged deep industry partnerships, including hosting AWS quantum and advanced computing labs on campus
  • Oversees patents, licensing, and startup formation across Caltech and NASA’s Jet Propulsion Laboratory
  • Blends engineering expertise with IP strategy as a registered U.S. patent agent
Why listen to him
Fred will share how to build university innovation platforms covering lab de-risking, EIRs, seed funds, and corporate R&D partnerships. Drawing on his work with AWS, JPL, and Caltech programs, he’ll show how to turn early inventions into global deep tech ventures.
Mr. Aditya Mathur
Managing Director, elev8 
Aditya leads Elev8.vc, a Singapore-based early-stage deep tech fund backing AI, robotics, quantum, medtech, and advanced materials across Asia-Pacific. With 25+ years in tech and investing, he brings a founder-first, engineering-driven approach.
Remarkable Achievements:
  • Founded Elev8.vc in 2018, closing its second Deep Tech Fund in early 2025
  • Scaled two multi-billion-dollar tech companies (software and hardware), both acquired
  • Pioneered a founder-aligned, value-accretive due diligence model for APAC deep-tech investing
Why listen to him
Aditya will share practical lessons on building deep tech funds, supporting engineering-driven start-ups, and bridging Eastern and Western innovation hubs. He’ll draw from his experience scaling tech ventures and shaping founder-aligned investment models for Asia’s next deep tech wave.
Dr. Thuc Vu
Co-Founder & CEO, OhmniLabs
Thuc co‑founded OhmniLabs, a Silicon Valley pioneer in affordable human‑centric telepresence and service robots. Before that, he built and exited multiple ventures Katango (acquired by Google) and Tappy (acquired by Weeby.co), demonstrating a strong entrepreneurial and technical track record.
Remarkable Achievements:
  • PhD in Computer Science from Stanford; BSc from Carnegie Mellon, focused on multi-agent systems and machine learning
  • Founded Katango and Tappy, acquired by Google and Weeby.co
  • Co-founded OhmniLabs (telepresence & disinfection robots), acquired by Symbotic in 2024
  • Named to Silicon Valley Business Journal’s 40 Under 40 in 2017
  • Co-founded VietSeeds and VietAI to support education and AI training in Vietnam
Why listen to him
Thuc will share how translational robotics, human-centric design, and university–industry partnerships can accelerate real-world impact. Drawing from his journey from Stanford research to global ventures, he’ll highlight lessons in scaling lab ideas in line with NUS Enterprise’s mission.
Mr. Paul Sciabetta
Co Founder & Managing Partner, 22Health Ventures
Paul is a global investor and entrepreneur, co-founder of 22Health Ventures, helping Singapore healthtech scale to the U.S. He brings 30+ years of private market and cross-border investment experience.
Remarkable Achievements:
  • Former CTO at Intel and VMware, where he scaled NSX into a $1B product
  • Co-founded Big Switch (acquired by Arista) and Voltage Security (acquired by HP)
  • Honored as MIT TR35 Innovator, WEF Tech Pioneer, and SIGCOMM Test-of-Time awardee
  • Holds a PhD from Stanford and an MS from Karlsruhe Institute of Technology
Why listen to him
Paul will share strategies for building global venture platforms that connect academic R&D with capital and execution. Drawing on his work with the NUS Medicine Digital Accelerator, he’ll explore U.S.–Asia market entry and aligning investors, universities, and startups to scale deep-tech and healthtech.
Prof. Oussama Khatib
Professor & Director of Stanford Robotics Lab, Stanford University
Oussama, Professor and Director of the Stanford Robotics Lab, is a pioneering roboticist known for advancing human-friendly robots, real-time control, and haptics.
Remarkable Achievements:
  • PhD in Electrical Engineering from Supélec; early work on real-time control and robot dynamics
  • Introduced key robotics concepts like artificial potential fields and operational space control
  • Created Stanford’s “Romeo” and “Juliet” platforms, advancing mobile and interactive robotics
  • Co-editor of the Springer Handbook and Tracts in Advanced Robotics
  • Honored with top awards including IEEE Technical Field, Engelberger, JRA, and France’s National Order of Merit
Why listen to him
Oussama will discuss advancing human-centered robotics through university, industry, and venture collaboration. Drawing on his experience turning lab innovations into real-world platforms, he’ll highlight models for consortia, partnerships, and commercialisation aligned with NUS Enterprise’s mission.
Dr. Dima Kuzmin
Managing Partner, 4BIO Capital
Dima co-founded 4BIO Capital, a London‑based VC firm exclusively focused on advanced and emerging therapies. A neuroscientist and technologist by training, he leads the firm’s technical strategy and in‑house research, bridging science and investment to cure chronic diseases.
Remarkable Achievements:
  • Holds dual MScs (Oxford, Moscow State) and a summa cum laude PhD in Neurochemistry
  • Pioneered chemogenetics research at Max Planck Institute and UCL
  • Adjunct Assistant Professor at Yale, Kauffman Fellow, and Fellow of the Royal Society of Biology
  • Led investments in 70+ advanced therapy companies, including IPOs (Orchard, ADC) and exits (RetroSense, RedPin)
  • Serves on boards of Araris, Trogenix, Hornet, Ray Therapeutics, and Code Bio
Why listen to him
Dima will share how academia-industry partnerships and early investment can accelerate tech transfer in advanced therapies, offering insights from translational science to global venture building and clinical impact.
Dr. Christopher Shen
Partner (Venture Investments), Novo
Christopher is a Partner at Novo Holdings, bringing 20+ years of global healthcare investment and medtech innovation. A physician, inventor, and investor, he bridges clinical insight with strategy, turning early-stage breakthroughs into real-world patient solutions.
Remarkable Achievements:
  • Holds an MD, MBA, and MS in Biomechanical Engineering from Stanford; Adjunct Professor of Medicine at Stanford
  • Former Senior Design Engineer at Guidant, lead inventor of an early stentriever device for stroke
  • Led U.S. healthcare ventures for Temasek/Vertex and Qiming US; later MD at CBC Group overseeing global investments
  • Board member of medtech companies including Moximed, Nuvaira, Supira, and Kona Medica
Why listen to him
Christopher will share how public–private partnerships, research, and venture capital can accelerate medical innovation. Drawing on his experience in clinical research and global funding, he’ll offer insights into turning early-stage breakthroughs into impactful, scalable technologies.
Dr. Guido Appenzeller
Partner (Investing), Andreessen Horowitz
Guido is a Partner at Andreessen Horowitz, where he focuses on transformative investments in AI, infrastructure, open-source technologies, and silicon. A seasoned entrepreneur and engineer, he brings deep technical insight to venture investing, informed by leadership roles at both startups and global tech firms.
Remarkable Achievements:
  • Former CTO of Intel’s Data Platforms Group, leading its data-centric tech strategy
  • Built VMware’s Cloud & Networking division, scaling NSX to a $1B USD product
  • Co-founded Big Switch (acquired by Arista) and Voltage Security (acquired by HP), serving as CEO/CTO
  • Named MIT TR35 Innovator, WEF Tech Pioneer, and SIGCOMM Test-of-Time awardee
  • Holds a PhD from Stanford and an MS from Karlsruhe Institute of Technology
Why listen to him
Guido will share how engineering insights drive smart AI-infrastructure investments—covering efficient model design, cloud-native scale, and the foundations of tomorrow’s tech stack.
Ms. Jenny Lee
Senior Managing Partner, Granite Asia
Jenny is a renowned Singaporean venture capitalist, currently working as a Senior Managing Partner at Granite Asia. A trailblazer in VC, she rose from engineering into finance and has become one of the first women to break into Forbes’ top 10 VC “Midas List”.
Remarkable Achievements:
  • Holds dual Electrical Engineering degrees from Cornell and an MBA from Kellogg
  • Co-led GGV’s Asia expansion, opening offices in China (2005) and Singapore (2019)
  • Led early investments in Alibaba, Didi, Xiaomi, Toutiao, Grab, and more
  • Portfolio includes 20+ unicorns and 16–17 IPOs across 5 global exchanges
  • Board member at Temasek International, Lee Kuan Yew School of Public Policy, and Duke-NUS Medical School
Why listen to her
Jenny will share insights from scaling venture ecosystems across Asia covering strategic investment, global tech pathways, and practical guidance for building impactful deep tech companies.
Mr. Sidu Ponnappa
Co-Founder & CEO Realfast
Sidu co-founded Realfast.ai in 2022, where he leads the development of AI-native sales agents designed to accelerate Salesforce implementations. A veteran of Silicon Valley and Southeast Asia, Sidu brings deep experience building engineering teams and scaling products at startups and tech unicorns.
Remarkable Achievements:
  • Co-founded C42 Engineering, acquired by Gojek in 2015; later led Gojek India’s engineering centre during its 900× scale-up
  • Scaled cross-functional teams at ThoughtWorks and Gojek, leading efforts in hiring, product, data, and platform
  • Founded Realfast.ai, enabling AI-driven Salesforce automation for IT services firms in Singapore and Bengaluru
  • Angel investor in early-stage start-ups, with public insights on agentic AI via Forbes India and major conferences
Why listen to him
Sidu will share lessons from scaling engineering teams and building AI-agent platforms, showing how to treat recruitment, product, and data as one system and how reusable AI-native architectures can drive faster innovation across ecosystems like NUS Enterprise.
Prof. Alberto Sangiovanni-Vincentelli
Edgar L. and Harold H. Buttner Chair of Electrical Engineering and Computer Science, UC Berkeley
Alberto, the Edgar L. and Harold H. Buttner Chair at UC Berkeley, is a legendary innovator and co-founder of Cadence and Synopsys, global leaders in Electronic Design Automation. With over 1,000 publications, 17 books, and 3 patents, he is an IEEE and ACM Fellow, and a member of the National Academy of Engineering and the American Academy of Arts and Sciences.
Remarkable Achievements:
  • Co-founder of Cadence and Synopsys, global EDA leaders that revolutionised the semiconductor industry
  • President of Chips.it, a $289M USD Italian foundation advancing innovation in chip design
  • Chair of Berkeley SkyDeck’s Academic Advisors, guiding one of Silicon Valley’s top accelerators
  • Special advisor for entrepreneurship to UC Berkeley’s Engineering Dean, building a strong startup ecosystem
  • Winner of the IEEE Maxwell Medal and 2023 BBVA Award for breakthroughs in electronics and chip automation
Why listen to him
Alberto helped turn academic research into $80B USD companies. He’ll share how world-class universities, strong investor networks, and visionary founders, advisors, and board members drive breakthrough innovation and lasting impact.